Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04104217
Other study ID # 19-270
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 23, 2019
Est. completion date August 18, 2023

Study information

Verified date August 2023
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to improve our understanding of the experience of music therapy by cancer patients with delirium, and the experience of music therapists working with these patients. The researchers are focusing on patients with delirium because of the challenging symptoms of this condition. At MSK, music therapy is routinely used in patients with cancer. Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date August 18, 2023
Est. primary completion date August 18, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - adult patients (ages 18-75) with delirium - referred for and receive music therapy. - were identified as having delirium by the Confusion Assessment Method (CAM), Confusion Assessment Method for ICU patients (CAM-ICU) or a documented diagnosis by a clinician from the Department of Psychiatry and Behavioral Sciences in the patient's electronic medical record (EMR). - Patients that have had music therapy in the past will be eligible for the study - Only patients that recover from delirium (per CAM, CAM-ICU, or progress note by a clinician from the Department of Psychiatry and Behavioral Sciences) after receiving music therapy will be approached for interview by the researcher. This study will also include their caregivers, music therapists, primary nurse, and bedside companions who have participated in or observed the participants' response to music therapy. The music therapist participants are: - Board-certified senior music therapists with 10 or more years experience in the research site who sign a blanket consent form to participate in study. - Assigned to eligible patients by Integrative Medicine Service Client Service Representative (CSR). The caregivers are: - Family or unrelated adult (>18) caregivers who observed bedside music therapy session(s) with patients meeting inclusion criteria The staff caregivers are: - Primary nurse caring for eligible patients who receive their first music therapy session while experiencing delirium. - Patient care technicians (PCT) assigned as bedside companions for eligible patients who receive music therapy Exclusion Criteria: - have a known hearing impairment - do not speak English. - are heavily sedated, comatose, or expected to be discharged or expire within 48 hours - have known comorbidities of delirium tremens, steroid psychosis, or dementia Caregivers will be excluded from the study if they do not speak English. Music therapists, nurses, or bedside companions will be excluded if they are not assigned to eligible patients.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Music therapy
Music therapy sessions may last 20-60 minutes, with length and frequency to be determined mutually (generally 1-3 times per week). Music therapy sessions are done at the patient's bedside, where the music therapist plays live music on a guitar, keyboard, harp, or percussion instrument, sometimes as accompaniment to singing.
Interviews
Each interview will be conducted in person in a private setting (with the exception of caregivers, who have the option to conduct interviews over the phone if it is not feasible to take place in the hospital). Each interview will follow a semi-structured interview guide and will ask for consent to audio record the interviews .

Locations

Country Name City State
United States Memorial Sloan Kettering Cancer Center New York New York

Sponsors (2)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center New York University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary thematic analysis of data with music therapists by interviews 1 year
Secondary thematic analysis of data with caregivers, nurses, and patients by interviews 1 year